BSE filing, NSE: VIJIFIN. Summary written from the filing by ALFA Finder's alert engine.
Viji Finance Ltd: key numbers
- Share price
- ₹15.08
- Market cap
- ₹348.4 Cr
- Revenue (annual)
- ₹5.08 Cr
- Net profit (annual)
- ₹1.97 Cr
- P/E (TTM)
- 60.7×Sector 19.7×
- Promoter holding
- 30.07%-9.24% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Viji Finance Ltd
All →Viji Finance Annual General Meeting
Viji Finance submitted a postal ballot notice to approve appointment of DDS & Associates as statutory auditors. The vote addresses the vacancy from the prior firm's resignation.
Viji Finance Q2 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
Viji Finance Ltd reported revenue from operations of ₹2.8 Cr (+366.7% YoY) and net profit of ₹1.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹1.5 Cr
Viji Finance Capital Structure Change
Viji Finance Ltd received listing approval from BSE and NSE for 1 crore equity shares issued upon conversion of warrants, valued at ₹2.80 Crore.
- Value
- ₹2.80 Cr
Viji Finance Board Meeting Date
Viji Finance has scheduled its Board meeting for 14 October 2026 to consider Q2/H1 results. No decisions have been taken yet; agenda items are proposed only.
Viji Finance Capital Structure Change
Viji Finance Limited received trading approval from BSE and NSE for 2,95,00,000 equity shares issued to non-promoters upon the conversion of warrants.
Viji Finance Capital Structure Change
Viji Finance Ltd allotted 8.85 crore equity shares upon conversion of warrants at Rs. 2.80 each. This capital change increases the company's paid-up share capital.
- Value
- ₹24.78 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.